Bovitrol (BioDeep_00000753843)

   


代谢物信息卡片


ALGESTONE ACETOPHENIDE

化学式: C29H36O4 (448.2613456)
中文名称: 苯乙酮
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CC(=O)C12C(CC3C1(CCC4C3CCC5=CC(=O)CCC45C)C)OC(O2)(C)C6=CC=CC=C6
InChI: InChI=1S/C29H36O4/c1-18(30)29-25(32-28(4,33-29)19-8-6-5-7-9-19)17-24-22-11-10-20-16-21(31)12-14-26(20,2)23(22)13-15-27(24,29)3/h5-9,16,22-25H,10-15,17H2,1-4H3

描述信息

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D011372 - Progestins
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone
D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents
D000893 - Anti-Inflammatory Agents

同义名列表

3 个代谢物同义名

ALGESTONE ACETOPHENIDE; Deladroxone; Bovitrol



数据库引用编号

10 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • O F Giwa-Osagie. Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland. Contraception. 1994 May; 49(5):421-33. doi: 10.1016/0010-7824(94)90001-9. [PMID: 8045129]
  • G W Sang. Pharmacodynamic effects of once-a-month combined injectable contraceptives. Contraception. 1994 Apr; 49(4):361-85. doi: 10.1016/0010-7824(94)90033-7. [PMID: 8013220]
  • J C Wiemeyer, C L Sagasta, J M Roncales Mateo, A C Lavarello, L A Angel de Toro, R Salas Diaz. Multicentred clinical study of the metabolic effect of the monthly injectable contraceptive containing dihydroxyprogesterone acetophenide 150 mg + estradiol enanthate 10 mg. Contraception. 1990 Jul; 42(1):13-28. doi: 10.1016/0010-7824(90)90088-d. [PMID: 2117515]
  • J Garza-Flores, V M Alba, M C Cravioto, L Hernandez, G Perez-Palacios, G Alvarado, R Rivera, R Recio, S Bassol. Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin. Contraception. 1989 May; 39(5):519-29. doi: 10.1016/0010-7824(89)90107-8. [PMID: 2524362]
  • R Schiavon, S Benavides, G Oropeza, J Garza-Flores, R Recio, V Díaz-Sanchez, G Pérez-Palacios. Serum estrogens and ovulation return in chronic users of a once-a-month injectable contraceptive. Contraception. 1988 Jun; 37(6):591-8. doi: 10.1016/0010-7824(88)90005-4. [PMID: 3396358]
  • P Larochelle, P Du Souich, E Bolte, J Lelorier, R Goyer. Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application. Clinical pharmacology and therapeutics. 1983 Mar; 33(3):343-50. doi: 10.1038/clpt.1983.43. [PMID: 6402333]
  • P A Gilles, H J Karavolas. Effect of 20 alpha-dihydroprogesterone, progesterone, and their 5 alpha-reduced metabolites on serum gonadotropin levels and hypothalamic LHRH content. Biology of reproduction. 1981 Jun; 24(5):1088-97. doi: . [PMID: 6791716]
  • A Rustrian. [A ten year clinical investigation of injectable contraceptives]. Investigacion medica internacional. 1980 Mar; 7(1):27-31. doi: NULL. [PMID: 12262411]
  • L Giuliani, D Pescatore, C Giberti. [Hormone therapy in renal adenocarcinoma]. Minerva chirurgica. 1977 Dec; 32(23-24):1463-5. doi: NULL. [PMID: 600435]
  • I F Lau, S K Saksena, M C Chang. Temporal changes in circulating steroids during prostaglandin F2alpha induced abortion in the rat and rabbit. Prostaglandins. 1976 May; 11(5):859-69. doi: 10.1016/0090-6980(76)90193-3. [PMID: 935516]
  • W S Arrata, R T Chatterton. Effect of prostaglandin F2alpha on the luteal phase of the cycle in nonpregnant women. American journal of obstetrics and gynecology. 1974 Dec; 120(7):954-9. doi: 10.1016/0002-9378(74)90345-7. [PMID: 4429112]
  • O Chieffi, L Bonardi, M Brogioni. [Use of an injectable hormonal contraceptive in a single monthly dose]. Archivio di ostetricia e ginecologia. 1974 Aug; 79(5-6):342-61. doi: ". [PMID: 4471562]
  • D Minucci, G Arreghini, A Rabasso. [Modification of the endometrium during combined therapy with dihydroxyprogesterone acetophenide and estradiol-3-benzoate-17-n-butyrate]. Rivista di ostetricia ginecologia pratica e medicina perinatale. 1973 197; 54(10):497-505. doi: NULL. [PMID: 4807299]
  • K Zaki, N Younis, H Nour. Steroid excretion in users of the injectable combined oestrogen progestogen preparation, deladroxate. The Egyptian population and family planning review. 1971 Dec; 4(2):1-5. doi: NULL. [PMID: 12255961]
  • M Lever. Some improvements on the fluorometric determination of serum corticosteroids. Clinical biochemistry. 1971 Jun; 4(2):68-75. doi: 10.1016/s0009-9120(71)90705-3. [PMID: 4256853]
  • I Kamal, F Hefnawi, N Younis, M Talaat, O Moheidin, S Ashmawy. Blood coagulation and fibrinolysis with an injectable long-acting progestogen-oestrogen contraceptive. The Egyptian population and family planning review. 1970 Jun; 3(1):5-10. doi: NULL. [PMID: 12254509]
  • J N Corriere, E E Wallach, J J Murphy, C R Garcia. Effect of anovulatory drugs on the human urinary tract and urinary tract infections. Obstetrics and gynecology. 1970 Feb; 35(2):211-6. doi: NULL. [PMID: 5414207]
  • H T Felton, E W Hoelscher, D P Swartz. Evaluation of use of an injectable progestin-estrogen for contraception. Fertility and sterility. 1965 Sep; 16(5):665-75. doi: 10.1016/s0015-0282(16)35713-2. [PMID: 5833974]